Biomedoz to close
Wednesday, 16 July, 2003
Online industry and share market watcher Biomedoz has called it a day. Last week, the site posted a note informing users that it would close "in the next couple of days".
Editor Bengt Norrman lamented the lack of interest realised by the site, from both industry and stakeholders. He described the last four years as "both fun and hard graft", but admitted that the company had failed to elicit a suitable partner to help fund the site and undertake further development.
"Philanthropy and love of the industry started Biomedoz," wrote Norrman. "Indifference and the hard cold facts of today's business environment brought it down. Perhaps there is one piece of hard-earned wisdom that we can share with you: philanthropy and business do not mix very well," he added.
Heart muscle regeneration genes mapped
Researchers have uncovered insights into how stem cells develop and mature into heart muscle...
The cause of 2022's mpox outbreak revealed
Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...
New gene therapy treats liver disorder in growing children
Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...
